The condom and sandal manufacturer said that demand for its products was continuing and it was experiencing an annual profit growth of 30 percent.
The company sells Durex and Scholl footwear.
Durex has benefited from good growth in the condom business, and another strong performance from the Durex Play range reflecting the launch of Play O and the continuing advance of the Durex Play Massage range.
Scholl Footcare has performed well due in part to the success of Scholl Perfect Nail Treatment and the initial roll out of the Scholl Biomechanics range. Scholl Footwear benefited from strong growth in Asia, coupled with a solid performance in the major European territories.
SSL made in excess of 640 million pounds last year.
SLL Chief Executive Garry Watts said: "As a consequence of this underlying sales growth, continuing cost control and the benefit from favourable currency rates, we continue to expect to announce reported operating profit growth in excess of 30 percent for the year ending March 31, 2009."
The company sells Durex and Scholl footwear.
Durex has benefited from good growth in the condom business, and another strong performance from the Durex Play range reflecting the launch of Play O and the continuing advance of the Durex Play Massage range.
Scholl Footcare has performed well due in part to the success of Scholl Perfect Nail Treatment and the initial roll out of the Scholl Biomechanics range. Scholl Footwear benefited from strong growth in Asia, coupled with a solid performance in the major European territories.
SSL made in excess of 640 million pounds last year.
SLL Chief Executive Garry Watts said: "As a consequence of this underlying sales growth, continuing cost control and the benefit from favourable currency rates, we continue to expect to announce reported operating profit growth in excess of 30 percent for the year ending March 31, 2009."
